Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2015
Synchronous glioblastoma and medulloblastoma in a child with mismatch repair mutation.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Amayiri Nisreen, Al-Hussaini Maysa, Swaidan Maisa, Jaradat Imad, Qandeel Monther, Tabori Uri, Hawkins Cynthia, Musharbash Awni, Alsaad Khulood, Bouffet Eric
Аннотация
Synchronous primary malignant brain tumors are rare. We present a 5-year-old boy with synchronous glioblastoma and medulloblastoma. Both tumor samples had positive p53 stain and loss of PMS2 and MLH1 stains. The child had multiple café au lait spots and a significant family history of cancer. After subtotal resection of both tumors, he received craniospinal radiation with concomitant temozolomide followed by chemotherapy, alternating cycles of cisplatin/lomustine/vincristine with temozolomide. Then, he started maintenance treatment with cis-retinoic acid (100 mg/m(2)/day for 21 days). He remained asymptomatic for 34 months despite a follow-up brain MRI consistent with glioblastoma relapse 9 months before his death. Cis-retinoic acid may have contributed to prolong survival in this child with a probable biallelic mismatch repair syndrome.
Предметные рубрики MeSH
Antineoplastic Combined Chemotherapy ProtocolsBrain NeoplasmsChild, PreschoolColorectal NeoplasmsCombined Modality TherapyCranial IrradiationFatal OutcomeGerm-Line MutationGlioblastomaHumansMaleMedulloblastomaMismatch Repair Endonuclease PMS2MutL Protein Homolog 1Neoplasms, Multiple PrimaryNeoplastic Syndromes, HereditaryTumor Suppressor Protein p53